Wegovy 1mg side effects: what most people notice at this stage

You've stepped up the dose, here's why 1mg feels different

Wegovy's titration schedule exists precisely to reduce how hard the gastrointestinal effects hit. You begin at 0.25mg for four weeks, then 0.5mg, then 1mg, each step up nudges the dose while giving your gut time to adjust. But that adjustment isn't instant, and the 1mg stage is the first point where most people feel a genuine therapeutic effect alongside a corresponding uptick in side effects.

Semaglutide slows gastric emptying. Food leaves the stomach more slowly than your body is used to, which is partly how it reduces appetite. At 1mg, this is more pronounced than at the earlier doses, and that's why nausea, a sense of fullness after small meals, burping and occasional vomiting are common. They're not signs something has gone wrong. They're the medicine doing what it's designed to do, at a strength your system hasn't encountered before.

Eating smaller portions, avoiding very fatty or rich food during the first couple of weeks, and not lying down immediately after meals all help. None of that replaces personalised guidance from your prescriber, who is the right person to talk to if symptoms are making daily life difficult. If you found the side effects of Wegovy 0.5 manageable and want to understand how this stage compares, that picture is covered separately, as is how side effects of the 1.7mg dose compare to where you are now.

The side effects reported most often at the 1mg stage

A question our prescribers hear most weeks is whether nausea at 1mg means the treatment isn't right for you. Usually it doesn't. The NHS lists the following as common effects of semaglutide: nausea, vomiting, diarrhoea, constipation, stomach pain, indigestion, reflux, burping, fatigue and dizziness. These are broadly the same at every dose; what changes is intensity.

At 1mg, nausea is the most reported, typically peaking in the first week after the step-up and settling by week two or three. Constipation and diarrhoea can alternate, which is disorienting if you're not expecting it. Headache and mild fatigue feature for some people, possibly linked to reduced calorie intake as appetite falls.

Injection-site reactions (redness, mild swelling or brief discomfort at the spot where the pen was used) are worth noting too. Rotating between the abdomen, thigh and upper arm generally keeps these manageable. The technique for using the Wegovy pen makes a practical difference here.

These effects are covered in detail in the patient information leaflet that comes with your pen. If yours is missing or unclear, the full summary is available through the electronic medicines compendium, which holds the Wegovy SmPC on the eMC.

When 1mg Wegovy side effects need medical attention

Most effects at this dose are uncomfortable rather than dangerous. A few are not, and it's worth knowing the difference before you feel unwell.

Pancreatitis is rare but serious. The MHRA updated its guidance in January 2026, specifically highlighting acute pancreatitis as a known risk with GLP-1 medicines. The signal to act is severe stomach pain that persists and may radiate toward the back, sometimes with vomiting. If that happens, stop the injection and contact a GP or NHS 111 promptly, don't wait to see if it passes.

Gallbladder problems, including gallstones, have been reported with semaglutide. Sudden pain in the upper right abdomen or under the right shoulder blade, especially after eating, is worth reporting to a doctor rather than managing at home.

Significant dehydration from repeated vomiting or diarrhoea can put strain on the kidneys. Lightheadedness, very dark urine or an inability to keep fluids down are reasons to seek medical help the same day. Signs of an allergic reaction (facial swelling, difficulty breathing, a spreading rash) need urgent emergency care.

For the broader safety context across the full dose range, the Wegovy overview page covers what the evidence says from 0.25mg through to 2.4mg and beyond. You can also see how the side-effect picture at the 2.4mg maintenance dose differs from what you're experiencing now.

What your prescriber needs to know, and why it matters before the next dose step

Wegovy is a prescription-only medicine. That means your next dose step to 1.7mg isn't automatic, it's a clinical decision, and how you're tolerating 1mg is central to it. If nausea has been severe, if you've lost significant weight already, or if a health condition has changed since your last review, your prescriber may hold the dose or adjust the plan.

This is why aftercare matters as much as the initial prescription. At nume, every repeat order is reviewed by a GPhC-registered prescriber before it's approved, the same clinical scrutiny, not a rubber stamp. Side effects you've noticed at 1mg are exactly the kind of information that shapes whether moving to the next step is right for you, or whether staying longer at 1mg makes more clinical sense.

The full Wegovy dose guide explains how the schedule is structured and what each step is intended to achieve. And if you're not yet on treatment but are weighing up whether Wegovy suits your situation, a free consultation with our prescribers is the first step, they discuss suitability and the likely side-effect profile as a standard part of that conversation. Speak to our prescribers to get started.